AI assistant
AbbVie Inc. — Director's Dealing 2014
Feb 24, 2014
29755_dirs_2014-02-24_dcd9b5d1-fe30-401f-888b-6ac30f92535b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2014-02-20
Reporting Person: SALEKI-GERHARDT AZITA (SVP, Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-20 | Common stock, $0.01 par value | A | 30140 | $0.00 | Acquired | 94607 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-02-20 | Option (right to buy) | $51.42 | A | 51990 | Acquired | 2024-02-19 | Common stock (51990) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $0.01 par value | 1700 | Indirect |
| Common stock, $0.01 par value | 918 | Indirect |
Footnotes
F1: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
F2: Balance in the AbbVie Savings Program as of February 20, 2014.
F3: The reporting person disclaims beneficial ownership of all securities held by her spouse.
F4: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 17,330 on 02/20/2015, 17,330 on 02/20/2016, and 17,330 on 02/20/2017.